BNP Paribas Financial Markets’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
FCM
LG
VCM
AI
DIG
BNP Paribas Financial Markets's STIM Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Neuronetics (STIM) stake by 1,694% in Q2 2026, buying an estimated $204K and bringing the position to 148,815 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #4252.
BNP Paribas Financial Markets first reported a position in STIM in Q1 2019 and has held it in 20 quarters since. 70 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- BNP Paribas Financial Markets held 148,815 shares of Neuronetics worth $193K as of Q2 2026.
- BNP Paribas Financial Markets bought 140,520 Neuronetics shares in Q2 2026, an estimated $204K.
- Neuronetics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4252 holding.
- BNP Paribas Financial Markets first reported a position in Neuronetics in Q1 2019 and has held it in 20 quarters since.
- 70 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.